Glutamate Receptor Interacting Protein 1 (Grip1 Protein) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@kim1999] title: GRIP1 Protein [@takeuchi1997] description: Glutamate Receptor Interacting Protein 1 - AMPA receptor scaffolding, synaptic plasticity, receptor trafficking [@sheng2001] tags: protein, neurodegeneration, PDZ domain proteins [@kennedy2000] .infobox.inbox-protein GRIP1 Protein === === Protein Name: Glutamate Receptor Interacting Protein 1 Gene: [GRIP1](/proteins/grip1-protein) UniProt ID: O75177 Molecular Weight: 150 kDa Protein Family: PDZ domain proteins Subcellular Localization: Postsynaptic membranes === ===
Overview
...
Glutamate Receptor Interacting Protein 1 (GRIP1 Protein)
Glutamate Receptor Interacting Protein 1 (Grip1 Protein) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@kim1999] title: GRIP1 Protein [@takeuchi1997] description: Glutamate Receptor Interacting Protein 1 - AMPA receptor scaffolding, synaptic plasticity, receptor trafficking [@sheng2001] tags: protein, neurodegeneration, PDZ domain proteins [@kennedy2000] .infobox.inbox-protein GRIP1 Protein === === Protein Name: Glutamate Receptor Interacting Protein 1 Gene: [GRIP1](/proteins/grip1-protein) UniProt ID: O75177 Molecular Weight: 150 kDa Protein Family: PDZ domain proteins Subcellular Localization: Postsynaptic membranes === ===
Overview
Glutamate Receptor Interacting Protein 1 is a protein encoded by the [GRIP1](/proteins/grip1-protein) gene. It belongs to the PDZ domain proteins and is primarily localized to Postsynaptic membranes.
Structure
GRIP1 is a 150 kDa protein with multiple domains that enable its scaffolding and signaling functions in [neurons](/entities/neurons).
Normal Function
AMPA receptor scaffolding, synaptic plasticity, receptor trafficking. This protein plays important roles in maintaining normal neuronal function and synaptic transmission.
Role in Neurodegeneration
Alterations in GRIP1 have been associated with several neurodegenerative and neurological disorders. Studies have shown changes in expression and mutations in various disease contexts.
Therapeutic Targeting
Research is ongoing to develop therapeutic approaches targeting GRIP1 for neurological disorders.
GRIP1 (Glutamate Receptor Interacting Protein 1) functions as a critical scaffold protein at excitatory synapses. It contains seven PDZ domains that mediate protein-protein interactions with various targets:
AMPA Receptor Subunits: GRIP1 binds to the C-terminal tails of GluA2/3 AMPA receptor subunits through its PDZ domains
IRSp53/MIM: Links to actin cytoskeleton for synaptic spine morphogenesis
CASK: Synaptic scaffold interactions
PICK1: Involved in receptor trafficking and plasticity
PDZ Domain Architecture
Expression Pattern
GRIP1 exhibits high expression in:
[Hippocampus](/brain-regions/hippocampus): Particularly CA1 and dentate gyrus regions
Small molecule stabilizers of GRIP1-AMPAR complexes
Research Directions
Current research focuses on:
Developing PDZ domain-selective compounds
Understanding GRIP1 isoform-specific functions
Investigating GRIP1 in network-level plasticity
Biomarker development for synaptic integrity
Background
The study of Glutamate Receptor Interacting Protein 1 (Grip1 Protein) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.